Peapack-Gladstone Financial Corporation (FRA:45V)

Intra-Cellular Therapies Revenue

Peapack-Gladstone Financial had revenue of $63.16M USD in the quarter ending June 30, 2025, with 19.87% growth. This brings the company's revenue in the last twelve months to $238.30M, up 16.62% year-over-year. In the year 2024, Peapack-Gladstone Financial had annual revenue of $220.39M with 2.25% growth.

• Revenue (ttm): $238.30M
• Revenue Growth: +16.62%
• P/S Ratio: 1.92
• Revenue / Employee: $384.35K
• Employees: 620
• Market Cap: 389.81M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	220.39M	4.86M	2.25%
Dec 31, 2023	215.54M	-20.58M	-8.72%
Dec 31, 2022	236.12M	32.74M	16.10%
Dec 31, 2021	203.37M	46.41M	29.57%
Dec 31, 2020	156.96M	-14.01M	-8.19%